DJO

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Retrieved on: 
Friday, April 5, 2024
DJO, KPMG, Foot, Sale, Controller, Senior, SMTI, History, BSN, Planet, Orthopedic surgery, Marketing, Corporate development

Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.

Key Points: 
  • Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.
  • Mr. Palmer brings extensive expertise in the healthcare sector, particularly in leading strategic growth and corporate development initiatives aimed at enhancing financial and clinical outcomes for providers, while maximizing shareholder returns.
  • In his most recent role, Mr. Palmer served as the Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions, a leading provider of outsourced revenue cycle and clinical documentation solutions.
  • Under his leadership, he crafted and executed a strategic vision that included multiple successful acquisitions and technology investments.

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Retrieved on: 
Monday, February 12, 2024
Acquisition, Standard, Comfort, ENOV, Surgeon, Knee pain, DJO, Vitamin E, ROAM, Augmented reality, Elective surgery, Deformity, Patient, Longevity, AAOS, Pressure, American Academy

WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024.

Key Points: 
  • WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024.
  • In addition, the Company will present itself as a newly integrated company following the acquisition of orthopedic leader LimaCorporate S.p.A (“Lima”).
  • In our Surgical business, the addition of Lima brings great technologies, capabilities and a product portfolio with demonstrated clinical excellence around the world.
  • Visit AAOS booth #1827 or www.enovis.com to learn how Enovis is developing innovative medical technology that continues to revolutionize the orthopedic industry.

Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting

Retrieved on: 
Monday, January 29, 2024
ACFAS, Foot, MIS, Deformity, Acquisition, Surgeon, DJO, American College, ENOV

WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle (ACFAS) annual meeting in Tampa, Fla., from February 1-4, 2024.

Key Points: 
  • WILMINGTON, DE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle (ACFAS) annual meeting in Tampa, Fla., from February 1-4, 2024.
  • “With a commitment to advancing technology and improving user experience, we are proud to share our newest technologies at this year’s meeting,” stated Gary Justak, President and General Manager of Enovis™ Foot and Ankle.
  • Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail® and DynaClip™ offerings in the hindfoot segment.
  • Enovis will also highlight products from its foot and ankle continuum of care, including the following products from its subsidiary DJO, LLC:

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Retrieved on: 
Thursday, January 25, 2024
Knee pain, Patient, Osteoarthritis, Knee, ROAM, Slim, Proprioception, Environment, Skin, Love, OA, Pressure, Pain, DJO, ENOV, Dentistry

WILMINGTON, DE, Jan. 25, 2024 (GLOBE NEWSWIRE) --  Enovis™ Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its DJO, LLC subsidiary has launched its new DonJoy® ROAM™ OA knee brace for patients with osteoarthritis or other knee pain and instability.

Key Points: 
  • WILMINGTON, DE, Jan. 25, 2024 (GLOBE NEWSWIRE) --  Enovis™ Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today that its DJO, LLC subsidiary has launched its new DonJoy® ROAM™ OA knee brace for patients with osteoarthritis or other knee pain and instability.
  • Designed for conservative care, preparation for surgery, or for postoperative knee protection, ROAM OA is ideal for a wide range of patients who want to maintain or increase activity.
  • “ROAM OA represents the next generation of unloader knee braces for active patients with pain due to osteoarthritis or other causes," said Terry Ross, Group President of Enovis Prevention & Recovery.
  • “It’s effective and easy for patients to use and easy for providers to prescribe, even for patients who would otherwise need a customized device.”
    For more information about the ROAM OA knee brace, visit www.enovis.com/roamoa .

Chamberlain Group Adds Two New Leaders to Executive Team to Continue Growth Trajectory

Retrieved on: 
Wednesday, January 24, 2024
Tonal, Science, CFO, Amazon, Athlete, Walmart, Ecosystem, PepsiCo, 1,000,000, Software, Sale, LeBron James, Chamberlain Group, Gatorade, CMO, OAK, Dell, DJO, EVP, Growth

OAK BROOK, Ill., Jan. 24, 2024 /PRNewswire/ -- Chamberlain Group (CG), global leader in intelligent access solutions and Blackstone portfolio company, welcomes two new executive leaders this month to accelerate the company's transformation.

Key Points: 
  • OAK BROOK, Ill., Jan. 24, 2024 /PRNewswire/ -- Chamberlain Group (CG), global leader in intelligent access solutions and Blackstone portfolio company, welcomes two new executive leaders this month to accelerate the company's transformation.
  • During his time at DJO, he navigated the sale of the company to a strategic buyer for $3 billion.
  • "Chamberlain Group is defining the intelligent access industry, and the transformation it's undergoing is incredible," said Mike Eklund.
  • "I look forward to working with the team to continue driving the company's impressive growth and momentum."

Enovis Announces Business Segment Leadership Transition Plan

Retrieved on: 
Tuesday, December 5, 2023
P&R, DJO, Global marketing, Commercial, Support, Recon, GM, Acquisition, Retirement, Brace, Business development, Organization, Growth, EGX, ENOV

Louie Vogt, president and general manager of surgical, has been promoted to Group President Reconstructive (Recon), a newly created role in which he will lead the Company’s global reconstructive business segment.

Key Points: 
  • Louie Vogt, president and general manager of surgical, has been promoted to Group President Reconstructive (Recon), a newly created role in which he will lead the Company’s global reconstructive business segment.
  • Louie has a proven track record driving double-digit growth and market outperformance in our U.S. surgical business through innovation and commercial excellence.
  • Terry has played a vital role in the return of our P&R segment to consistent growth and strong cash flow.
  • Mr. Vogt joined DJO (now Enovis) in 2017, leading the Surgical Global Product Management and US Sales Organizations before becoming President of the Enovis U.S. surgical business.

Global Foot And Ankle Devices Markets, 2023-2030: Digital Healthcare Takes Center Stage in Foot and Ankle Surgeries - ResearchAndMarkets.com

Retrieved on: 
Friday, July 21, 2023
Medical Devices, Health, Ankle, Obesity, Diabetes, Ankle fracture, COVID-19, DJO, Foot, Trauma, American Academy, Apple Watch, Falls, USD, Elective surgery, Athlete, Max Trax, Incidence, Digital technology, Patient, Atmosphere of Earth, Growth, Johnson & Johnson, WHO, AAOS, Robotics, ProCare, Conference, Enovis, Injury, Medical device, Pharmaceutical industry, Dentistry, Osteoarthritis

This was mainly due to a decreased number of surgeries related to the foot and ankle.

Key Points: 
  • This was mainly due to a decreased number of surgeries related to the foot and ankle.
  • Also, COVID-19 has dramatically improved the role of digital healthcare in foot and ankle surgeries.
  • At the American Academy of Orthopedic Surgeons (AAOS) Conference 2021, many orthopedic athletes showcased their dedication to digital orthopedic treatment.
  • Johnson & Johnson demonstrated their VELYS Digital Surgical Platform, which uses robotics, data insights, and digital technology to enhance patient care.

Daniel J. Ocasio Earns 2023 Attorney of the Year Award

Retrieved on: 
Thursday, January 26, 2023
IRS, CFTC, Lawyer, Durable medical equipment, DJO, FCA, Ocasio, MCO, Fraud, FCPA, Pharmaceutical industry

WASHINGTON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Professional organization Lawyers of Distinction has named DJO Whistleblower Law Group's Daniel J. Ocasio "Attorney of the Year" in their 2023 membership selection, recognizing him for Excellence in Federal False Claims law.

Key Points: 
  • WASHINGTON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Professional organization Lawyers of Distinction has named DJO Whistleblower Law Group's Daniel J. Ocasio "Attorney of the Year" in their 2023 membership selection, recognizing him for Excellence in Federal False Claims law.
  • The Lawyers of Distinction Selection Committee uses these criteria to determine a cumulative, minimum passing score of acceptance.
  • "This is an incredible honor, one that wouldn't be possible without the work of our dedicated team," said Daniel J. Ocasio, Managing Partner of DJO Whistleblower Law Group.
  • Ocasio founded DJO Whistleblower Law Group (DJO) after his groundbreaking respiratory fraud case against Apria Healthcare Group in 2017.

Orthopaedic Industry Annual Report 2022: Leading Players, Product Segments, Revenue Figures and Forecasts, Growth drivers and Challenges - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022
Health, Other Health, RTI, DJO, RTI Surgical, COVID-19, Elective surgery, Globus Medical, Kyocera

The "The Orthopaedic Industry Annual Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Orthopaedic Industry Annual Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • Global orthopedic sales totaled $53.6 billion in 2021, an increase of 12.8% compared to 2020.
  • Published in late spring/early summer each year, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT is the definitive source for orthopedic market intelligence by reviewing key industry trends, highlighting strategic product launches and M&A activity, and offering a five-year forecast of the market.
  • We cover the leading players; product segments, revenue figures and forecasts, growth drivers and challenges.

Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery

Retrieved on: 
Tuesday, July 19, 2022
Medical Devices, Health, Surgery, Health Technology, General Health, Biotechnology, Culture, DJO, Knee, Acquisition, Hip, Patient, Solution, Hospital, Mayo Clinic, Surgeon, Mayo, Information system, Osteoarthritis, NYSE, Technology, Arthritis, Cartilage, Disability, General manager, LLC, Teaching hospital, AR, Elective surgery, ENOV, Orthopedic surgery, FDA, Medical device

This FDA-cleared system is the only proprietary, real-time, hands-free augmented reality (AR) technology precisely engineered for orthopedic surgeons, so they can visualize precision guidance when performing hip and knee surgery with the support of AR.

Key Points: 
  • This FDA-cleared system is the only proprietary, real-time, hands-free augmented reality (AR) technology precisely engineered for orthopedic surgeons, so they can visualize precision guidance when performing hip and knee surgery with the support of AR.
  • AR technology is a form of orthopedic surgical guidance technology that helps surgeons place and align implants during surgery.
  • ARVIS is the first system with proprietary hardware designed to assist surgeons in precisely placing hip and knee joint replacements, to help improve joint replacement recovery outcomes.
  • Hip or knee replacement is the standard treatment for osteoarthritis, the most common form of arthritis and the most common cause of disability in adults.